Fibroblast growth factor 13(FGF13)is aberrantly expressed in multiple cancer types,suggesting its essential role in tumorigenesis.Hence,we aimed to explore its definite role in the development of acute myeloid leukemi...Fibroblast growth factor 13(FGF13)is aberrantly expressed in multiple cancer types,suggesting its essential role in tumorigenesis.Hence,we aimed to explore its definite role in the development of acute myeloid leukemia(AML)and emphasize its associations with bone marrow niches.Results showed that FGF13 was lowly expressed in patients with AML and that its elevated expression was related to prolonged overall survival(OS).Univariate and multivariate Cox regression analyses identified FGF13 as an independent prognostic factor.A prognostic nomogram integrating FGF13 and clinicopathologic variables was constructed to predict 1-,3-,and 5-year OS.Gene mutation and functional analyses indicated that FGF13 was not associated with AML driver mutations but was related to bone marrow niches.As for immunity,FGF13 was remarkably associated with T cell count,immune checkpoint genes,and cytokines.In addition,FGF13 overexpression substantially inhibited the growth and significantly induced the early apoptosis of AML cells.The xenograft study indicated that FGF13 overexpression prolonged the survival of recipient mice.Overall,FGF13 could serve as an independent prognostic factor for AML,and it was closely related to the bone marrow microenvironment.展开更多
Methyl-CpG binding protein 2 （MeCP2） has a crucial role in transcriptional regulation and neural development （Ausi6 et al., 2014）. Loss of function mutations of MECP2 in human lead to Rett syndrome （RTT）, a seve...Methyl-CpG binding protein 2 （MeCP2） has a crucial role in transcriptional regulation and neural development （Ausi6 et al., 2014）. Loss of function mutations of MECP2 in human lead to Rett syndrome （RTT）, a severe neurodevelopmental disorders （Amir et al., 1999）, whereas individuals with the chromosomal duplications containing the MECP2 locus showed severe autism-like symptoms （Ramocki et al., 2009）.展开更多
基金supported by the National Key Research and Development Program of China(No.2019YFA0905900).
文摘Fibroblast growth factor 13(FGF13)is aberrantly expressed in multiple cancer types,suggesting its essential role in tumorigenesis.Hence,we aimed to explore its definite role in the development of acute myeloid leukemia(AML)and emphasize its associations with bone marrow niches.Results showed that FGF13 was lowly expressed in patients with AML and that its elevated expression was related to prolonged overall survival(OS).Univariate and multivariate Cox regression analyses identified FGF13 as an independent prognostic factor.A prognostic nomogram integrating FGF13 and clinicopathologic variables was constructed to predict 1-,3-,and 5-year OS.Gene mutation and functional analyses indicated that FGF13 was not associated with AML driver mutations but was related to bone marrow niches.As for immunity,FGF13 was remarkably associated with T cell count,immune checkpoint genes,and cytokines.In addition,FGF13 overexpression substantially inhibited the growth and significantly induced the early apoptosis of AML cells.The xenograft study indicated that FGF13 overexpression prolonged the survival of recipient mice.Overall,FGF13 could serve as an independent prognostic factor for AML,and it was closely related to the bone marrow microenvironment.
基金supported by the Strategic Priority Research Program of Chinese Academy of Sciences(Grant No.XDB02050400)the National Natural Science Foundation of China(Grant No. #91432111) to Z.Qiu
文摘Methyl-CpG binding protein 2 （MeCP2） has a crucial role in transcriptional regulation and neural development （Ausi6 et al., 2014）. Loss of function mutations of MECP2 in human lead to Rett syndrome （RTT）, a severe neurodevelopmental disorders （Amir et al., 1999）, whereas individuals with the chromosomal duplications containing the MECP2 locus showed severe autism-like symptoms （Ramocki et al., 2009）.
